Ubiquisys Small Cell Innovation
Ubiquisys is a pioneer in small cell and femtocell technology. Unlike other companies, Ubiquisys has specialised in small cells from the outset, and does not produce technology at the core network end of a small cell solution, such as gateways and management systems. This focus has resulted in a unique range of small cell technologies, and it has made it much easier to interoperate with gateway vendors, using open standard interfaces.
Ubiquisys has developed a range of patented technologies that together address all of the novel requirements for a successful commercial deployment of small cells:
- Interference – for small cells to complement existing networks, they must not cause interference problems, and so must autonomously adapt to changing radio conditions.
- Scale – small cells are being deployed in huge numbers, making traditional management methods impossible. Small cells must be self-managing, making their own decisions based on operator policies.
- High availability – in busy public access environments, small cells must be able to meet the service quality KPIs of the macro network without manual engineering intervention.
- Resilience – with minimal manual intervention in set-up and operation, and situated at the end of a commodity backhaul connection, it is essential that small cells have the systems to enable self-healing, recovery and upgrade.
- Group behaviour – increasingly, mall cells are deployed in groups as self-organising networks (SON). This extends the utility of small cells, but places new demands on their ability to act autonomously.
- Applications – there is a great opportunity to serve and process content at the edge of the network, from inside small cells, where content is closer to mobile users. Specific new technology is required to make this happen.
Ubiquisys small cell innovation can be summarised like this:
